Download fulltext
HTML
1.
Abtahi S-H, Nouri H, Moradian S, Yazdani S, Ahmadieh H. Editorial – Eye Disorders in the Post-COVID Era. JOVR [Internet]. 2021Oct.25 [cited 2024Apr.18];16(4):527–530. Available from: https://knepublishing.com/index.php/JOVR/article/view/9740
https://doi.org/10.18502/jovr.v16i4.9740
statistics
- 1192 Abstract Views
- 549 PDF Views
- 0 HTML Views
- Cited by 2 articles
authors
-
Seyed-Hossein Abtahi
Seyed-Hossein Abtahi
Ophthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
-
Hosein Nouri
Hosein Nouri
Ophthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
-
Siamak Moradian
Siamak Moradian
Ophthalmic Epidemiology Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
-
Shahin Yazdani
Shahin Yazdani
Ophthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
-
Hamid Ahmadieh
Hamid Ahmadieh
Ophthalmic Research Center, Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Published Date
- Oct 25, 2021
Editorial – Eye Disorders in the Post-COVID Era
Abstract
This is an Editorial and does not have an abstract. Please download the PDF or view the article HTML.
Keywords:
Not applicable
References
1. Banoun H. Evolution of SARS-CoV-2: review of mutations, role of the host immune system. Nephron 2021;145:392–403.
2. Roshanshad A, Ali Ashraf M, Roshanshad R, Kharmandar A, Alireza Zomorodian S, Ashraf H. Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res 2021;16:234–247.
3. Dumitrascu OM, Volod O, Bose S, Wang Y, Biousse V, Lyden PD. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis 2020;29:104982.
4. Raevis JJ, Gjyzeli G, Mititelu M, Rogers J, Lasarev M, Chang JS. Face masks and bacterial dispersion toward the periocular area. Ophthalmology 2021;128:1236–1238.
5. Marin-Nieto J, Reino-Perez C, Santillana-Cernuda G, Díaz-Bernal JM, Luque-Aranda R, García-Basterra I. Face mask contamination during COVID-19 pandemic. Study on patients receiving intravitreal injections. Retina 2021; Online ahead of print.
6. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383–388.
7. Parke DW. Ophthalmology after coronavirus disease 2019 (COVID-19). JAMA Ophthalmol 2020;138:599.
8. Berkenstock MK, Liberman P, McDonnell PJ, Chaon BC. Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic. BMC Ophthalmol 2021;21:139.
9. Dexamethasone in Hospitalized Patients with Covid- 19. N Engl J Med 2021;384:693–704.
10. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf 2016;15:457–465.
11. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403–420.
12. Mohan R, Muralidharan AR. Steroid induced glaucoma and cataract. Indian J Ophthalmol 37:13–16.
13. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68:1119–1124.
14. Richardson RB, Ainsbury EA, Prescott CR, Lovicu FJ. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation. Int J Radiat Biol 2020;96:1339– 1361.
15. Clark A, Morlet N, Ng JQ, Preen DB, Semmens JB. Risk for retinal detachment after phacoemulsification. Arch Ophthalmol 2012;130:882.
16. Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res 2012;47:66– 80.
17. Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, et al. Steroidinduced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol 2020;65:458–472.
18. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009;15:469–474.
19. Matsumoto K, Yamasaki H, Akazawa S, Sakamaki H, Ishibashi M, Abiru N, et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 1996;81:2621–2626.
20. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 2014;30:96–102.
21. Homayounieh F, Holmberg O, Umairi R Al, Aly S, Basevičius A, Costa PR, et al. Variations in CT utilization, protocols, and radiation doses in COVID-19 pneumonia: results from 28 countries in the IAEA study. Radiology 2021;298:E141–E151.
22. Hauptmann M, Daniels RD, Cardis E, Cullings HM, Kendall G, Laurier D, et al. Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis. JNCI Monogr 2020;2020:188–200.
23. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369–384.
24. Pandya A, Lodha P. Social connectedness, excessive screen time during COVID-19 and mental health: a review of current evidence. Front Hum Dyn 2021;3.
25. Wong CW, Tsai A, Jonas JB, Ohno-Matsui K, Chen J, Ang M, et al. Digital screen time during the COVID- 19 pandemic: risk for a further myopia boom? Am J Ophthalmol 2021;223:333–337.
26. Kamiya K, Igarashi A, Hayashi K, Negishi K, Sato M, Bissen-Miyajima H. A multicenter prospective cohort study on refractive surgery in 15011 eyes. Am J Ophthalmol 2017;175:159–168.
27. Berkowitz ST, Sternberg P, Patel S. Cost analysis of routine vitrectomy surgery. Ophthalmol Retin 2021;5:496–502.
2. Roshanshad A, Ali Ashraf M, Roshanshad R, Kharmandar A, Alireza Zomorodian S, Ashraf H. Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res 2021;16:234–247.
3. Dumitrascu OM, Volod O, Bose S, Wang Y, Biousse V, Lyden PD. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis 2020;29:104982.
4. Raevis JJ, Gjyzeli G, Mititelu M, Rogers J, Lasarev M, Chang JS. Face masks and bacterial dispersion toward the periocular area. Ophthalmology 2021;128:1236–1238.
5. Marin-Nieto J, Reino-Perez C, Santillana-Cernuda G, Díaz-Bernal JM, Luque-Aranda R, García-Basterra I. Face mask contamination during COVID-19 pandemic. Study on patients receiving intravitreal injections. Retina 2021; Online ahead of print.
6. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383–388.
7. Parke DW. Ophthalmology after coronavirus disease 2019 (COVID-19). JAMA Ophthalmol 2020;138:599.
8. Berkenstock MK, Liberman P, McDonnell PJ, Chaon BC. Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic. BMC Ophthalmol 2021;21:139.
9. Dexamethasone in Hospitalized Patients with Covid- 19. N Engl J Med 2021;384:693–704.
10. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf 2016;15:457–465.
11. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403–420.
12. Mohan R, Muralidharan AR. Steroid induced glaucoma and cataract. Indian J Ophthalmol 37:13–16.
13. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68:1119–1124.
14. Richardson RB, Ainsbury EA, Prescott CR, Lovicu FJ. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation. Int J Radiat Biol 2020;96:1339– 1361.
15. Clark A, Morlet N, Ng JQ, Preen DB, Semmens JB. Risk for retinal detachment after phacoemulsification. Arch Ophthalmol 2012;130:882.
16. Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res 2012;47:66– 80.
17. Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, et al. Steroidinduced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol 2020;65:458–472.
18. Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009;15:469–474.
19. Matsumoto K, Yamasaki H, Akazawa S, Sakamaki H, Ishibashi M, Abiru N, et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 1996;81:2621–2626.
20. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 2014;30:96–102.
21. Homayounieh F, Holmberg O, Umairi R Al, Aly S, Basevičius A, Costa PR, et al. Variations in CT utilization, protocols, and radiation doses in COVID-19 pneumonia: results from 28 countries in the IAEA study. Radiology 2021;298:E141–E151.
22. Hauptmann M, Daniels RD, Cardis E, Cullings HM, Kendall G, Laurier D, et al. Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis. JNCI Monogr 2020;2020:188–200.
23. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369–384.
24. Pandya A, Lodha P. Social connectedness, excessive screen time during COVID-19 and mental health: a review of current evidence. Front Hum Dyn 2021;3.
25. Wong CW, Tsai A, Jonas JB, Ohno-Matsui K, Chen J, Ang M, et al. Digital screen time during the COVID- 19 pandemic: risk for a further myopia boom? Am J Ophthalmol 2021;223:333–337.
26. Kamiya K, Igarashi A, Hayashi K, Negishi K, Sato M, Bissen-Miyajima H. A multicenter prospective cohort study on refractive surgery in 15011 eyes. Am J Ophthalmol 2017;175:159–168.
27. Berkowitz ST, Sternberg P, Patel S. Cost analysis of routine vitrectomy surgery. Ophthalmol Retin 2021;5:496–502.